Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial.
Saved in:
| Title: | Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial. |
|---|---|
| Authors: | Voskaridou E; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, Athens, Greece., Ntanasis-Stathopoulos I; Department of Clinical Therapeutics and., Papaefstathiou A; Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, National and Kapodistrian University of Athens School of Medicine, Athens, Greece; and., Christoulas D; Department of Hematology and., Dimopoulou M; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, Athens, Greece., Repa K; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, Athens, Greece., Papatheodorou A; Department of Biomedical Research, 251 General Air-Force Hospital, Athens, Greece., Peppa M; Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, National and Kapodistrian University of Athens School of Medicine, Athens, Greece; and., Terpos E; Department of Clinical Therapeutics and. |
| Source: | Blood advances [Blood Adv] 2018 Nov 13; Vol. 2 (21), pp. 2837-2847. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
